✦ LIBER ✦

Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy

✍ Scribed by Vasiliki Pappa; Konstantinos Girkas; Constantina Sambani; Sotiris Pagageorgiou; Panagiotis Tsirigiotis; Kiki Karvounis; Evangelia Stathopoulou; Theofanis Economopoulos; George Dimitriadis; Ioannis Dervenoulas

Book ID: 113773623
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 196 KB
Volume: 36
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2011.11.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy-related acute myeloid leukemia (

✍ Mario Ojeda-Uribe; Anne Schneider; Isabelle Luquet; Ana Berceanu; Pascale Cornil 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Gemtuzumab ozogamicin, mitoxantrone, and

Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy

✍ Michael Boyiadzis; Robert L. Redner; Anastasios Raptis; Jing-Zhou Hou; Mounzer A 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 71 KB

Horner syndrome in a newly diagnosed pat

Horner syndrome in a newly diagnosed patient with high risk precursor b-cell acute lymphoblastic leukemia

✍ Thomas J. Fountaine; Brooke Miller; Yousuf M. Khalifa; Jeffrey R. Andolina 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Multivariate and subgroup analyses of a

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

✍ Mayer, Jiří; Arthur, Christopher; Delaunay, Jacques; Mazur, Grzegorz; Thomas, Xa 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 207 KB

Prognostic impact of DNMT3A mutations in

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia

✍ Jana Marková; Petra Michková; Kateřina Burčková; Jana Březinová; Kyra Michalová; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB